Neurotrophic Keratitis: Early Detection and Therapeutic Optimization
This activity is supported by an educational grant from Dompé US, Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Dompé US, Inc.
Activity Description
Neurotrophic keratitis (NK) is a degenerative corneal disease characterized by a decrease in corneal sensitivity. Diagnosis in the early stages of NK can be challenging if patients are experiencing few symptoms, but if left undiagnosed and untreated, complications such as corneal ulceration, stromal melting, and vision loss can occur. Corneal sensitivity testing is essential in the diagnosis of NK. When integrated properly into management protocols, current and emerging treatment options can restore corneal sensitivity, promote healing, and stop disease progression. In this CE monograph, experts in the field discuss best practices for the early diagnosis of NK, including corneal sensitivity testing. Faculty will also review clinical evidence for current and investigational NK therapies, using case-based examples to highlight approaches to diagnosis and treatment of NK across various its disease stages.
Target Audience
The intended audience for this activity is ophthalmologists and other healthcare professionals involved in the management of patients with NK.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Employ corneal sensitivity testing and other diagnostic modalities for the staging and early detection of NK.
- Utilize the clinical evidence for current and investigational therapies for the management of NK.
Activity Chair
Brandon D. Ayres, MD
Cornea Service
Co-Director of Cornea Fellowship
Wills Eye Hospital
Philadelphia, PA
Faculty
Francis S. Mah, MD
Director, Cornea Service
Co-Director, Refractive Surgery
Scripps Clinic
La Jolla, CA
Lisa M. Nijm, MD, JD
Founder, MDNegotiation.com
Founder, RealWorldOphthalmology.com
CEO, Women in Ophthalmology
Founder and Medical Director, Warrenville EyeCare and LASIK
Assistant Clinical Professor of Ophthalmology
University of Illinois Eye and Ear Infirmary
Chicago, IL
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Medical Writer
Valerie Zimmerman, PhD
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, April 30, 2024, to April 29, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
The articles in this monograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Ayres, Mah, and Nijm during a live satellite symposium held on January 13, 2024. The monograph has been approved by each of the faculty individually as an accurate representation of their presentations.
Activity Chair and Faculty report the following relevant financial relationship(s)
Brandon D. Ayres, MD
Consultant: Alcon, Allergan, Bausch + Lomb, Glaukos, Zeiss
Francis S. Mah, MD
Advisor: Alcon, Aldeyra, Allergan, Aperta, Avellino, Bausch + Lomb, Dermavant, Dompé, EyeYon, GSK, iView, Johnson & Johnson Vision, Kala, Kiora, Mallinckrodt, Novartis, NuLids, Ocular Therapeutix, OcuTerra, Okogen, PolyActiva, Sun, Sydnexis
Consultant: Alcon, Aldeyra, Allergan, Aperta, Avellino, Bausch + Lomb, Dermavant, Dompé, EyeYon, GSK, iView, Johnson & Johnson Vision, Kala, Kiora, Mallinckrodt, Novartis, NuLids, Ocular Therapeutix, OcuTerra, Okogen, PolyActiva, Sun, Sydnexis
Individual Stocks and Stock Options (publicly traded): Kala
*Individual Stocks and Stock Options (privately held): Avellino
Lisa M. Nijm, MD, JD
Consultant: Alcon, Allergan, Azura Ophthalmics, Bausch + Lomb, Bruder, BVI Medical, Centricity Vision, Dompé, Johnson & Johnson Vision, Novartis, Ocular Therapeutix, Orasis, Oyster Point, Rayner, Scope Health, Sun, Thea, Trukera Medical, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon, Allergan, Bausch + Lomb, Novartis, Oyster Point, Sun
Independent Research Contractor: Ocular Therapeutix
Individual Stocks and Stock Options (publicly traded): Trukera Medical
Planners/Reviewers reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Medical Writer reports the following relevant financial relationship(s)
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com